Familial striatal degeneration: New mutation and neuroimaging clues.

Neurology

From the Universidade Federal de São Paulo (O.G.P.B., J.L.P.); Jardim Cuiabá Hospital (P.d.M.M.), Cuiabá, MT; Universidade de São Paulo School of Medicine (H.F.C.); Pontifícia Universidade Católica do Paraná (PUCPR) Curitiba (S.R.), PR; Genetika-Centro de Aconselhamento e Laboratório de Genética (S.R.), Curitiba, PR, Brazil; the University of North Carolina at Chapel Hill (R.H.N.); and Santa Casa de Misericórdia de São Paulo (R.H.N., A.J.d.R.), Brazil.

Published: November 2015

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002128DOI Listing

Publication Analysis

Top Keywords

familial striatal
4
striatal degeneration
4
degeneration mutation
4
mutation neuroimaging
4
neuroimaging clues
4
familial
1
degeneration
1
mutation
1
neuroimaging
1
clues
1

Similar Publications

Introduction: Alzheimer's disease (AD) in Down syndrome (DS) is associated with changes in brain structure. It is unknown if thickness and volumetric changes can identify AD stages and if they are similar to other genetic forms of AD.

Methods: Magnetic resonance imaging scans were collected for 178 DS adults (106 nonclinical, 45 preclinical, and 27 symptomatic).

View Article and Find Full Text PDF

Children and adolescents with neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) may be more susceptible to early life stress compared to their neurotypical peers. This increased susceptibility may be linked to regionally-specific changes in the striatum and amygdala, brain regions sensitive to stress and critical for shaping maladaptive behavioural responses. This study examined early life stress and its impact on striatal and amygdala development in 62 children and adolescents (35 males, mean age = 10.

View Article and Find Full Text PDF

The neurotransmitter dopamine (DA) has a multifaceted role in healthy and disordered brains through its action on multiple subtypes of dopaminergic receptors. How modulation of these receptors influences learning and motivation by altering intrinsic brain-wide networks remains unclear. Here we performed parallel behavioral and resting-state functional MRI experiments after administration of two different DA receptor antagonists in male and female macaque monkeys.

View Article and Find Full Text PDF

Design and synthesis of novel benzoic acid derivatives as striatal-enriched protein tyrosine phosphatase (STEP) inhibitors with neuroprotective properties.

Eur J Med Chem

February 2025

Department of Medicinal Chemistry and Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China; State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Normal University, Guilin, 541004, China. Electronic address:

As a central nervous system-specific member of the protein tyrosine phosphatase (PTP) family, the striatal-enriched protein tyrosine phosphatase (STEP) is an attractive drug target for neurodegenerative diseases. Here, we reported the discovery of a series of benzoic acid derivatives as new STEP inhibitors. Among them, compound 14b exhibited good STEP inhibitory activity and displayed selectivity against other PTPs.

View Article and Find Full Text PDF

In recent years, special attention has been paid to highlighting the antiparkinsonian effect of linagliptin. However, the mechanism of its action has not yet been well investigated. The present study aimed to verify the neuroprotective effect of linagliptin in the rotenone model of Parkinson's disease (PD) and further explore its potential molecular mechanisms.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!